7 alpha-hydroxy-4-cholesten-3-one has been researched along with ezetimibe in 1 studies
Studies (7 alpha-hydroxy-4-cholesten-3-one) | Trials (7 alpha-hydroxy-4-cholesten-3-one) | Recent Studies (post-2010) (7 alpha-hydroxy-4-cholesten-3-one) | Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) |
---|---|---|---|---|---|
134 | 28 | 59 | 2,484 | 563 | 1,465 |
Protein | Taxonomy | 7 alpha-hydroxy-4-cholesten-3-one (IC50) | ezetimibe (IC50) |
---|---|---|---|
NPC1-like intracellular cholesterol transporter 1 | Homo sapiens (human) | 0.37 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeBarber, AE; Jones, PJH; Mymin, D; Myrie, SB; Othman, RA; Roullet, JB; Steiner, RD | 1 |
1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and ezetimibe
Article | Year |
---|---|
Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.
Topics: Adolescent; Adult; Anticholesteremic Agents; Cholestanol; Cholestenones; Cholesterol; Ezetimibe; Female; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Phytosterols; Sitosterols; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult | 2017 |